Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Riley Hospital for Children
mi
from
Indianapolis, IN
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Children's Hospital of Iowa
mi
from
Iowa City, IA
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Children's Hospital of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Children's Hospital of Akron
mi
from
Akron, OH
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Children's Hospital of Akron
mi
from
Akron, OH
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Columbus Children's Hospital
mi
from
Columbus, OH
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Columbus Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Driscoll Children's Hospital
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Children's Medical Center of Dallas
mi
from
Dallas, TX
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Children's Medical Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients
Status: Enrolling
Updated:  3/22/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients
Status: Enrolling
Updated: 3/22/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients
Status: Enrolling
Updated:  3/22/2018
IWK Health Centre
mi
from
Halifax,
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients
Status: Enrolling
Updated: 3/22/2018
IWK Health Centre
mi
from
Halifax,
Click here to add this to my saved trials
Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement
Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.
Status: Enrolling
Updated:  3/22/2018
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement
Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.
Status: Enrolling
Updated: 3/22/2018
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Status: Enrolling
Updated:  3/24/2018
David Grant Medical Center
mi
from
Fairfield, CA
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Status: Enrolling
Updated: 3/24/2018
David Grant Medical Center
mi
from
Fairfield, CA
Click here to add this to my saved trials
EEG Characteristics in Youth POTS and/or Syncope
Electroencephalographic (EEG) Characteristics of Postural Tachycardia Syndrome (POTS) and Syncope (Without POTS) During Head-upright Tilt Table Testing
Status: Enrolling
Updated:  3/25/2018
Nationwide Children's Hopsital
mi
from
Columbus, OH
EEG Characteristics in Youth POTS and/or Syncope
Electroencephalographic (EEG) Characteristics of Postural Tachycardia Syndrome (POTS) and Syncope (Without POTS) During Head-upright Tilt Table Testing
Status: Enrolling
Updated: 3/25/2018
Nationwide Children's Hopsital
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
Status: Enrolling
Updated:  3/25/2018
Piedmont Healthcare
mi
from
Atlanta, GA
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
Status: Enrolling
Updated: 3/25/2018
Piedmont Healthcare
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
Status: Enrolling
Updated:  3/25/2018
ZNA Middelheim
mi
from
Antwerp,
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
Status: Enrolling
Updated: 3/25/2018
ZNA Middelheim
mi
from
Antwerp,
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Victoria Heart and Vascular Center
mi
from
Victoria, TX
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Comprehensive Cardiovascular Medical Group
mi
from
Bakersfield, CA
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Comprehensive Cardiovascular Medical Group
mi
from
Bakersfield, CA
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Texas Institute of Cardiology
mi
from
McKinney, TX
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Texas Institute of Cardiology
mi
from
McKinney, TX
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Cardiology Consultants
mi
from
Pensacola, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Cardiology Consultants
mi
from
Pensacola, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Tampa General Hospital
mi
from
Tampa, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
MedStar Shah Medical Group
mi
from
Charlotte Hall, MD
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
MedStar Shah Medical Group
mi
from
Charlotte Hall, MD
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Advanced Cardiology Group
mi
from
Buffalo, NY
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Advanced Cardiology Group
mi
from
Buffalo, NY
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University of Calgary
mi
from
Calgary,
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Yale-New Haven Hospital
mi
from
New Haven, CT
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Cardiology Physicians/Red Clay Research
mi
from
Newark, DE
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Cardiology Physicians/Red Clay Research
mi
from
Newark, DE
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Bethesda Health
mi
from
Boynton Beach, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Bethesda Health
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
South Miami Heart Specialists
mi
from
South Miami, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
South Miami Heart Specialists
mi
from
South Miami, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Northwestern University
mi
from
Evanston, IL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Northwestern University
mi
from
Evanston, IL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
WakeMed
mi
from
Raleigh, NC
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
WakeMed
mi
from
Raleigh, NC
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Houston Methodist Hospital
mi
from
Houston, TX
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
VA Connecticut Healthcare System (VACHS)
mi
from
West Haven, CT
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
VA Connecticut Healthcare System (VACHS)
mi
from
West Haven, CT
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University of Florida Health - Jacksonville
mi
from
Jacksonville, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University of Florida Health - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University of South Florida
mi
from
Tampa, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Augusta University
mi
from
Augusta, GA
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
MMP ME Health Cardiology
mi
from
Scarborough, ME
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
MMP ME Health Cardiology
mi
from
Scarborough, ME
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Boston Med Ctr
mi
from
Boston, MA
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Department of Cardiology, K-14 (Henry Ford Health System)
mi
from
Detroit, MI
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Department of Cardiology, K-14 (Henry Ford Health System)
mi
from
Detroit, MI
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University at Buffalo
mi
from
Buffalo, NY
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Vascular Biology and Hypertension Program, University of Alabama at Birmingham
mi
from
Birmingham, AL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Vascular Biology and Hypertension Program, University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Sharp Grossmont Hospital
mi
from
La Mesa, CA
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Sharp Grossmont Hospital
mi
from
La Mesa, CA
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Veterans Affairs North Texas Healthcare System
mi
from
Dallas, TX
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Veterans Affairs North Texas Healthcare System
mi
from
Dallas, TX
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Regions Hospital and Regions Heart Center Clinic
mi
from
Saint Paul, MN
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Regions Hospital and Regions Heart Center Clinic
mi
from
Saint Paul, MN
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Montefiore Medical Center
mi
from
Bronx, NY
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University of Miami Hospital
mi
from
Miami, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University of Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Rush University Medical Center
mi
from
Chicago, IL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
Cedars-Sinai Medica Center
mi
from
Los Angeles, CA
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
Cedars-Sinai Medica Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
Evanston Hospital / North Shore University HealthSystem
mi
from
Evanston, IL
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
Evanston Hospital / North Shore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
Massachusetts General Hospital
mi
from
Boston, MA
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
Henry Ford Hospital
mi
from
Detroit, MI
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
The Mayo Clinic
mi
from
Rochester, MN
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials